|
|
Article: CardiacAssist Expands Market Penetration of TandemHeart[R] Extracorporeal Circulatory Support System among Heart Surgeons, Cardiologists and Electrophysiologists.(Report)
- Article from:
- Heart Disease Weekly
- Article date:
- November 22, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CardiacAssist Inc.: (Click here to see video, "A Patient Success Story") Privately held CardiacAssist Inc. announced that the Cardiovascular Institute of Stanford (University) Hospital & Clinics (Palo Alto, Calif.) is one of the newest cardiac centers to begin using TandemHeart[R], the Company's FDA-cleared extracorporeal circulatory support system. TandemHeart is now being used in nearly 90% of the "Best U.S. Heart & Heart Surgery Hospitals" as ranked by U.S. News & World Report, with nearly 1,800 procedures performed at nearly 150 hospitals across the United States. Last month, CardiacAssist announced record nine-month financial results for 2009 compared to results for ...